Afya Limited Announces Closing of the Acquisition of Além da Medicina
Afya Limited (Nasdaq: AFYA) announced the successful acquisition of 100% of Além da Medicina through its subsidiary, Afya Participações S.A. This medical content platform offers valuable resources for physicians and medical students, contributing to Afya's digital ecosystem. With over 4,000 subscribers and a projected gross revenue of R$12.7 million for 2022, Além da Medicina enhances Afya's educational capabilities. The acquisition cost was R$16 million, fully paid in cash, with potential earn-outs of up to R$19.2 million based on performance metrics for 2023 and 2024.
- Acquisition of Além da Medicina enhances Afya's educational content and technology capabilities.
- Além da Medicina had over 4,000 subscribers and is projected to generate R$12.7 million in gross revenue for 2022.
- Potential earn-out of R$19.2 million based on revenue goals for 2023 and 2024 adds incentive for growth.
- The full cash payment of R$16 million may strain available liquidity.
- Integration challenges could arise given the reliance on performance metrics for additional earn-outs.
Além da Medicina is a medical content online platform for physicians and medical students that provides educational tools besides technical medical content that can assist them throughout their careers. Its robust content includes mentoring for residency, soft skills, finance, accounting, and investment basics for physicians.
Além da Medicina had more than 4.000 subscribers in 2021, with a general NPS of 77 and almost 100.000 followers on Instagram. The company expects
This business combination incorporates new capabilities to the content & technology for the medical education pillar and further strengthens
The aggregate purchase price (enterprise value) paid to sellers was
About
View source version on businesswire.com: https://www.businesswire.com/news/home/20220304005580/en/
Investor Relations Contact:
ir@afya.com.br
Media Contact:
Cíntia
cintia.marin@afya.com.br
Source:
FAQ
What is Afya Limited's recent acquisition news?
What is the value of Afya's acquisition of Além da Medicina?
What are the expected revenues from Além da Medicina?
How does the acquisition impact Afya's market position?